Nanoparticles News and Research

RSS

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

In a recent bioRxiv preprint research paper, Botond Z. Igyártó and colleagues from Thomas Jefferson University demonstrated the inflammatory nature of the lipid nanoparticles (LNPs).

15 Mar 2021

Neuroprotectant-loaded nanoparticles may reduce stroke severity, improve survival

When NA1, a neuroprotectant, was delivered to the brain in nanoparticles, it reduced stroke severity and improved survival in a mouse model of stroke, according to preliminary research to be presented at the American Stroke Association's International Stroke Conference 2021.

11 Mar 2021

Study: Graphene nanoparticles interfere with the development of anxiety-related behaviors in vertebrates

New research shows that the nanomaterial acts on the excitatory synapses, interfering with the development of anxiety related behaviors in vertebrates.

11 Mar 2021

New high-performance, safe MRI contrast agent for 3D vascular mapping

Heart attack and stroke are the first and second leading causes of death in developed countries, respectively. As the disease often results in sudden death with few special prognostic symptoms, early diagnosis is very important.

10 Mar 2021

Simple blood test using nanoparticles could enable earlier detection of acute liver damage

University of Texas at Dallas chemist Dr. Jie Zheng has spent much of his career investigating gold nanoparticles for their potential impact in the field of nanomedicine.

10 Mar 2021

Vaccine mRNA not found in breast milk after COVID mRNA vaccination

A study conducted by researchers in the United States has found no evidence to suggest that the messenger RNA (mRNA) present in the Pfizer-BioNTech and Moderna vaccines that protect against coronavirus disease 2019 (COVID-19) can be transferred to human breast milk.

9 Mar 2021

Scientists develop RNA-based therapeutic strategy for Charcot-Marie Tooth disease

Charcot-Marie Tooth disease is the most common hereditary neurological disease in the world. It affects the peripheral nerves and causes progressive paralysis of the legs and hands.

9 Mar 2021

Bruker announces new results in deep, unbiased plasma proteomics, PaSER 1.1 software and new cross-linking consumables at US HUPO 2021

At the virtual 17th US HUPO Conference (US HUPO 2021), Bruker Corporation (Nasdaq: BRKR) today announces progress with several collaborations in deep, unbiased plasma proteomics, leveraging the speed, sensitivity and dynamic range of 4D proteomics on timsTOF Pro systems.

From Bruker Daltonics 9 Mar 2021

New biosensor measures extracellular hydrogen peroxide levels with nanometer-resolution

Several processes in the human body are regulated by biochemical reactions involving hydrogen peroxide (H2O2).

8 Mar 2021

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

The currently developed vaccines against SARS-CoV-2 include the RBD in their immunogen. With a similar objective, a new study developed an RBD protein-based vaccine candidate against the SARS-CoV-2, using self-assembling Helicobacter pylori-bullfrog ferritin nanoparticles as an antigen delivery system. The study is published recently in the journal mBio (by the American Society of Microbiology).

8 Mar 2021

Gold nanocomposite contact lenses for correcting color blindness

Imagine seeing the world in muted shades -- gray sky, gray grass. Some people with color blindness see everything this way, though most can't see specific colors.

3 Mar 2021

Coronavirus-like nanoparticles could serve as a positive control for COVID-19 tests

Rapid COVID-19 tests are on the rise to deliver results faster to more people, and scientists need an easy, foolproof way to know that these tests work correctly and the results can be trusted. Nanoparticles that pass detection as the novel coronavirus could be just the ticket.

2 Mar 2021

New nanoparticle-delivered COVID-19 vaccine candidate shows efficacy in ferret model

Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease models.

2 Mar 2021

Evonik partners with BioNTech to manufacture lipids for COVID-19 vaccine

Caused by SARS-CoV-2, the coronavirus disease 2019 (COVID-19) pandemic continues to spread across the globe.

From Evonik 2 Mar 2021

Graphene oxide-silver nanoparticles shown to rapidly neutralize RNA viruses

While the vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are administered, and extensive research is conducted for targeted therapeutics to control the COVID-19 (coronavirus disease 2019), it is equally crucial to develop more novel, broad-spectrum antiviral compounds.

2 Mar 2021

Unique nanoparticles can package and deliver gene-editing machinery to the liver

The genome editing technology CRISPR has emerged as a powerful new tool that can change the way we treat disease. The challenge when altering the genetics of our cells, however, is how to do it safely, effectively, and specifically targeted to the gene, tissue and organ that needs treatment.

2 Mar 2021

Nanobowls show potential for diagnostics and treatment of Alzheimer's

Scientists are still a long way from being able to treat Alzheimer's Disease, in part because the protein aggregates that can become brain plaques, a hallmark of the disease, are hard to study.

26 Feb 2021

KAUST researchers develop a safe, fast and cheap testing method to detect viruses

A safe, fast and cheap testing method that uses magnetic nanoparticles to detect viruses in both clinical and wastewater samples has been developed by KAUST researchers.

25 Feb 2021

Novel single-particle digital assay using plasmonic nanobubbles

An interdisciplinary team from the University of Texas applied DIAMOND to the respiratory syncytial virus (RSV) diagnostics and demonstrated that DIAMOND is 150 times more sensitive than commercial lateral flow assays. They found that the measurements are completed within 2 minutes. The results of this study are published on the medRxiv* preprint server.

25 Feb 2021

New book focuses on rational drug design and discovery

Frontiers in Drug Design and Discovery is a book series devoted to publishing the latest and the most important advances in drug design and discovery.

25 Feb 2021

Nanoparticles News and Research

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

Neuroprotectant-loaded nanoparticles may reduce stroke severity, improve survival

Study: Graphene nanoparticles interfere with the development of anxiety-related behaviors in vertebrates

New high-performance, safe MRI contrast agent for 3D vascular mapping

Simple blood test using nanoparticles could enable earlier detection of acute liver damage

Vaccine mRNA not found in breast milk after COVID mRNA vaccination

Scientists develop RNA-based therapeutic strategy for Charcot-Marie Tooth disease

Bruker announces new results in deep, unbiased plasma proteomics, PaSER 1.1 software and new cross-linking consumables at US HUPO 2021

New biosensor measures extracellular hydrogen peroxide levels with nanometer-resolution

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

Gold nanocomposite contact lenses for correcting color blindness

Coronavirus-like nanoparticles could serve as a positive control for COVID-19 tests

New nanoparticle-delivered COVID-19 vaccine candidate shows efficacy in ferret model

Evonik partners with BioNTech to manufacture lipids for COVID-19 vaccine

Graphene oxide-silver nanoparticles shown to rapidly neutralize RNA viruses

Unique nanoparticles can package and deliver gene-editing machinery to the liver

Nanobowls show potential for diagnostics and treatment of Alzheimer's

KAUST researchers develop a safe, fast and cheap testing method to detect viruses

Novel single-particle digital assay using plasmonic nanobubbles

New book focuses on rational drug design and discovery

How to solve the hidden bottleneck in lipid nanoparticle development eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News